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Biomedical field is constantly requesting for new biomaterials,
with innovative properties. Natural polymers appear as
materials of election for this goal due to their biocompatibility
and biodegradability. In particular, materials found in marine
environment are of great interest since the chemical and
biological diversity found in this environment is almost
uncountable and continuously growing with the research in
deeper waters. Moreover, there is also a slower risk of these
materials to pose illnesses to humans.
In particular, sulfated polysaccharides can be found in
marine environment, in different algae species. These poly-
saccharides don’t have equivalent in the terrestrial plants and
resembles the chemical and biological properties of mam-
malian glycosaminoglycans. In this perspective, are receiving
growing interest for application on health-related fields. On
this review, we will focus on the biomedical applications of
marine algae sulfated polymers, in particular on the devel-
opment of innovative systems for tissue engineering and drug
delivery approaches.
Introduction
As a response to trauma or tissue disease, the human body tries to
remodel the injured tissue, but for many situations, these efforts
result in dysfunctionality and then tissue failure.1
To address this serious health problem, scientists have
dedicated great attention aiming at developing alternative
therapeutic solutions, to overcome the drawbacks of the current
clinical practices (prosthesis, autografts, allografts, xenografts, with
insufficient properties, site morbidity, donor scarcity and risk of
immune rejection as main drawbacks). In this regard, regenerative
medicine arose as a hot medical topic, with Langer and Vacanti
defining tissue engineering, in their seminal paper, as a
multidisciplinary approach that uses principles of engineering
and life sciences to create a new tissue.2 Following the general
strategy, a porous structure is developed in which cells are seeded/
cultured, under certain conditions, with defined biochemical and
mechanical cues, until obtaining a functional tissue substitute to
be subsequently implanted in the patient injury site.
Such porous structures—called scaffolds—are requested to
exhibit certain properties, such as biocompatibility both in as-
implanted form and after degradation, which should occur in
controlled manner, present appropriate mechanical properties to
meet the needs of the tissue to be regenerated, adequate surface
properties to enhance interaction with cells and optimal three-
dimensional structure (porosity, pore size and interconnectivity).
Thus, different processing technologies have been proposed to
prepare such structures,3,4 for instance foaming,5,6 freeze-drying,7-9
fiber extrusion and bonding,10,11 three-dimensional printing,12,13
porogen leaching,14-16 in situ pore forming,17 particle aggrega-
tion,18-20 electrospinning,21,22 supercritical fluids technology23,24
and use of ionic liquids.25
Together with several techniques, a wide range of materials
have been also proposed, including natural and synthetic polymers
or a conjugation of both. More recently, considering their
predominant existence in the extracellular matrix, but also because
of their low immunogenicity and enhanced interaction with
growth factors, attention has been devoted to glycosaminoglycans,
namely hyaluronic acid and chondroitin sulfate.26,27 Despite the
incomplete understanding of the interactions between cells and
extracellular matrix, namely at molecular level, it is known that
glycosaminoglycans modulate the adhesion of progenitor cells and
their subsequent differentiation and gene expression. In particular,
degree of sulfation, molecular weight and structural composition
influence cell behavior, with changes being observed in different
physiological but also pathological processes.27
In fact, degree of sulfation seems to play such a relevant role
that recent efforts have been focusing on the preparation and
further use of highly sulfated glycosaminoglycans derivatives, in
particular by introducing sulfate features in hyaluronic acid or
increasing sulfate degree of chondroitin sulfate. Interesting
findings have been observed, as the enhanced binding of growth
factors to sulfate hyaluronic acid when comparing with
chondroitin sulfate with the same sulfation degree, which has
been attributed to differences in the sulfation pattern.28 This is in
agreement with the findings of Gama and coworkers, where the
precise position of sulfate groups resulted in specific ligand-
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receptor interactions, according to a kind of sulfation code.29 This
specificity results in different cellular behavior: sulfate hyaluronic
acid was observed to promote proliferation of dermal fibroblasts,26
but on the case of rat calvarial osteoblasts such proliferation was
hindered.30 It is noteworthy that the mentioned improved
proliferation of fibroblasts was followed by a reduced extracellular
matrix expression, which might be quite interesting for skin
regeneration, namely by promoting wound closure while
hindering scar formation.26 Besides effects on cell adhesion and
proliferation, sulfate groups were shown to also influence cell
differentiation: matrices of collagen II and sulfate hyaluronic acid
stimulate osteogenic differentiation of human mesenchymal stem
cells.31 In order to shed more light on the mechanism of influence
of sulfate groups on cell behavior, the specific effect of sulfate
groups, disconnected from the glycosaminoglycan environment,
was also assessed. Sulfate-rich surfaces were prepared with self-
assembled monolayers of v-sulfatealkanethiols, which were shown
to influence cell morphology and mobility with enhanced
formation of filopodia in both bone marrow derived mesenchymal
stem cells and adipose derived stem cells.32
Having in mind this huge potential of sulfate groups, research
communities have also been looking at other ways to achieve
glycosaminoglycans and sulfated polysaccharides besides chemical
modification. In fact, such polysaccharides can be found in
marine organisms, in particular macroalgae.33 Besides being an
under-exploited resource, marine environments also possess an
enormous chemical and biological variety, thus being an
extraordinary source of biomaterials.34 On the particular case of
sulfated polysaccharides bearing glycosaminoglycan-like biological
properties, different structures can be found in marine macro-
algae, and its marine origin promises potentially safer polymers
when compared with mammalian alternatives,33 since their
associated risk of posing diseases to humans is not an issue. In
the present review, focus will be made on the most representative
sulfate polysaccharides that can be obtained from each of the three
main classes of macroalgae, mainly carrageenans, ulvan and
fucoidan from red, green and brown algae, respectively, and the
attempts to use them further, particularly in biomedical
applications, including tissue engineering approaches.
Sulfated Polysaccharides from Red Algae
Carrageenans are sulfated polysaccharides that occur as matrix
material in several species of red seaweeds (Rhodophyceae), with
main sources being Chondrus crispus, Gigartina, Eucheuma cottonii
and spinosum, and that can be extracted with water or aqueous
alkali methods.35-37 Chemically, these hydrophilic colloids are
highly sulfated galactans, with sulfate content varying between
15% and 40%,38 with a primary structure based on an alternating
sequence of β (1–4) and a (1–3) linked D-galactose residues,39
resulting in polymers with molecular weight ranging from 105 to
106 Da.40,41 The number and position of sulfate groups in the
repeating galactose units allows the classification of carrageenans
in three main commercially relevant families: kappa (k), iota (i)
and lambda (l). Table 1 summarizes the main characteristic
features of each of these carrageenan families, as well as a
representative scheme of the repeating unit structure.
It should be stressed that carrageenans can be quite
heterogeneous, either due to differing molecular structures within
the chains, to differing chains within the seaweed (hybrids) or to
algae species, ecophysiology and seasonality or even extraction
conditions.42,43 Thus a wide variety of materials can be obtained
from them, including hydrogels with a vast range of properties.44
In fact, the gel formation is one of the most relevant properties
in carrageenans, even though not possible with l-carrageenan
(being although used as thickening agent to control viscosity).
Table 1. Structural formula and typical properties of k-, i-, and l- carrageenans196,197
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The gelling mechanism is not known in detail, but its high
hydration capacity, the structural type, temperature, polymer
concentration and the presence of cations are key factors.45-47 k-
Carrageenan hydrogels are thermoreversible48 and can be formed
by ionic gelation through interaction with cations, particularly
with potassium (K+), which inhibits the electrostatic repulsion
between the neighboring negatively charged helices, allowing their
aggregation (Fig. 1).49,50 By their turn, i-carrageenan hydrogels
exhibit the interesting feature of spontaneously reforming once
the mechanical disruption action has stopped,51 called thixotropy,
very useful in certain applications, such as cosmetic emulsions.
The versatility of carrageenans is also patent on its several
processing and formulation routes. Besides hydrogels, carragee-
nans can also be processed into fibers by wet spinning, into
membranes by casting and further crosslinking or into porous
structures by freeze drying.52 In addition, the combination of two
different families of carrageenans has also been tested, for instance
on the production of microscale fibers.53 Hydrogel systems based
on carrageenan and other materials from natural algae origin,
namely alginate, have been developed into different formats
(beads/fibers);52,54,55 fibers resulting from wet-spinning carragee-
nan into chitosan or vice versa are also possible, including together
with carbon nanotubes to improve significantly their mechanical
properties, in which active ingredients can be trapped;56 chitosan/
carrageenan/tripolyphosphate nanoparticles exhibiting small size
and high positive charge have been produced by polyelectrolyte
complexation/ionic gelation;57 Fe3O4 nanoparticles with k-
carrageenan58,59 and spheres of carrageenans crosslinked by
paramagnetic ions (Ho3+)60 have also been developed.
The chemical reactivity of carrageenans, mainly due to the
sulfate groups, as well as the diversity of carrageenan structures
just described, can justify the application of carrageenans in
numerous applications.61,62 For example, their reactivity with
proteins, due to interactions between the sulfate groups of the
carrageenan and the charged groups of the protein, is present in
the interaction with casein in milk, extremely important in the
dairy industry;63,64 their ability to bind heavy metals through
covalent, electrostatic or redox reaction is useful for removing
them from contaminated waters, with clear environmental
impact;65,66 their unique properties of interaction with polyols
can be useful to control the texture of any formulation of
polyols.67 Nevertheless, their major industrial applications is as
thickening, emulsifier, gelling and stabilizing agents, such as for
example, in salad dressings, processed meat,68,69 abovementioned
dairy industry,70-73 and personal care products,74,75 but also in
pharmaceuticals formulations,76,77 being considered a good
substitute for gelatin.
In addition to the mentioned applications, the use of
carrageenans in the biomedical field is also being explored,
mainly taking advantage of their biological activities mostly
related to the sulfate content.78,79 In this sense, the antioxidant
activity of k-carrageenan has been investigated,80 as well as the
protective activity against viral, fungal and bacterial infections.81
Based on these known biological activities, carrageenans have been
tested as treatments for respiratory weakness, from the common
cold until influenza viruses, including the pandemic H1N1
influenza strain,82 but also against other viruses, such as dengue
virus, hepatitis A virus and African swine fever virus,83,84 or even
as topical microbicide targeting HIV and herpes viruses.85,86 In
other works, the in vivo antitumor and immunomodulation
activities of carrageenan has been studied, with low molecular
weight molecules showing the highest activities.87 Furthermore,
carrageenan has recently been used in a clinical trial to
significantly reduce serum cholesterol and triglyceride levels,88
presenting anticoagulant properties,89,90 and also a regulatory role,
namely on growth factors.91,92 Nevertheless, carrageenan biocom-
patibility has been questioned in the literature, with examples of
inflammatory response being presented.93,94 However, it should
be noted that food-grade carrageenan and degraded carrageenan
(low molecular weight) have completely different toxicological
properties,95,96 and not all the studies of acute toxicity have
sufficient details on dose, type of carrageenan, seaweed source or
extraction procedures used.97 Thus, carrageenan biocompatibility
is an open debate.
From all these facts, the use of carrageenans in diverse medical
applications has been considered, and the tissue engineering field
is no exception, with a few works reporting its use in the recent
years and more are expected to come.98 In this perspective,
carrageenan has been considered for growth factor/drug delivery
systems,99,100 and for immobilization of enzymes,101 but also in
encapsulation of several cell types for their in vivo delivery,102,103
envisioning cartilage regeneration. In fact, the structural resemb-
lance of these naturally occurring sulfated polymers to the
cartilage extracellular matrix components, glycosaminoglycans
(GAGs), may confer biochemical reactivity that urge to
determine. Addressing this, hydrogel based on k-carrageenan
was studied for the encapsulation of human-adipose-derived stem
cells, human nasal chondrocytes, or a chondrocytic cell line,
proving to be a good support for cell culture, viability, cartilage
matrix extracellular formation and chondrogenic
differentiation.100,103
Sulfated Polysaccharides from Green Algae
As in other macroalgae classes, sulfated polysaccharides can be also
found in green algae, but with more complex and diverse
Figure 1. Gelation model of k-carrageenan (adapted from refs194,195): by
decreasing temperature of carrageenan solution, a coil-to-helix con-
formational transition is enhanced; with further decrease in temperature,
in the presence of cations such as potassium, an organization and
aggregation of helices is promoted, forming a gel network.
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chemistries.104,105 In fact, different genus or species may synthesize
distinct sulfated polysaccharides with distinct sugar composi-
tion.104,106 In this regard, Percival propose a division of these green
algae in diverse groups according to the synthesized sulfated
polysaccharide, namely (sulfated) glucuronoxylorhamnans,
glucuronoxylorhamnogalactans and xyloarabinogalactans.104
However, an accurate division is much more complex: literature
is rich in research works reporting sulfated polysaccharides
extracted from different green algae (as exemplified in Table 2).
For instance, Codium fragile is known to possess a sulfated
heteropolysaccharide mainly composed of arabinose and galactan
moieties.104,107,108 On the other hand, a pyruvylated galactan
sulfate was obtained from Codium yezoense109 and Codium
fragile,110,111 whereas a sulfated mannan was extracted from
Codium vermilara112 but sulfated arabinan and sulfated arabino-
galactan were the ones identified in Codium dwarkense Boergs
extracts.113 Within other genus, such variability can also be
found.110,114-117 A genus of green algae receiving particular
attention for the extraction of sulfated polysaccharide is Ulva,
from which ulvan can be obtained, a polysaccharide mostly
composed of rhamnose, uronic acid and xylose.118-125
This variety of chemistries that can be found in sulfated
polysaccharides from green algae is substantiated by the numerous
oligosaccharide moieties identified as constituting the basic
structural units of these complex polysaccharides. In an interesting
review paper,106 Stengel and coworkers highlight this variability
and its relevance and impact in prospect applicative science based
on algal origin molecules.106 In fact, such variability, attributed to
taxonomic, ecological or environmental issues,106,126-128 should
always be regarded. Despite this chemical variability, certain
biological effects are common. In fact, sulfated polysaccharides are
commonly investigated for their biological properties, and the
ones obtained from green algae are no exception. A summary of
reported activities demonstrated in these polysaccharides is
presented in Table 3.
For instance, these polysaccharides exhibit antioxidant effects,
as was recently reported in several research works, describing
sulfated polysaccharides with superoxide and hydroxyl radicals
scavenging activity, reducing power and able to chelate
metals.129-135 Antitumoral activity and antiproliferative effects
have also been described and associated with these polysacchar-
ides.129,131,136 Another important features of these polysaccharides
are their immunostimulating ability, similar to other algal
polysaccharides,137-141 as well as their heparin-like character.105
Besides, these polysaccharides are largely studied for their
antihyperlipidemic activities,130,142-145 or antiviral
effects.111,131,146-148
Although common to the several sulfated polysaccharides
extracted from green algae, the expression of those biological
activities is dependent on different sugar composition, molecular
weight and sulfate content,149 and thus, as abovementioned, on
genus, species and ecological and environmental factors. Several
studies stress this variability regarding heparin-like behavior
according to the genus and species of the studied
algae,115-117,129,131,150-152 but similar variability can be found on
anticoagulant150-152 and antioxidant activities,133-135 as well as on
antiproliferative effect, which was shown to be strongly related
with the polysaccharide sulfate content.129
Within this scenario, an attractive use and exploitation of green
algae would take advantage of these biological properties and
translate them into applications with pharmacological and medical
relevance. However, among the three main divisions of macro-
algae, green algae remain a rather underexploited biomass,
particularly in areas where other algal origin polysaccharides have
already proven their value. A striking example of commercial
success is carrageenan (as discussed in the previous section).
Alongside its biological activity and potential pharmaceutical
use, green algae sulfated polysaccharides may also be used for
biomedical applications, in areas as demanding as regenerative
medicine. In this particular arena, both their biological activities
and their resemblance with glycosaminoglycans might position
these polysaccharides in an advantageous point. In this regard,
some important research work has already been performed related
with polysaccharide modification, processing and biomaterial
development, particularly using ulvan as a starting material.
Described ulvan structures include nanofibers,153 membranes,154
particles,155 hydrogels156 and 3D porous structures.157 The
applicability of these structures may range from drug delivery to
wound dressing or bone tissue engineering.153-157
Sulfated Polysaccharides from Brown Algae
Brown macroalgae are rich in polysaccharides such as alginic acids
(alginate) or laminarins (laminarans), but also sulfated fucans,
namely fucoidan, which are potential therapeutic agents.158
Fucoidan is found in the cells walls of these algae, representing
5% to 20% of the algae dry weight.159 Its history starts in 1913,
when it was named fucoidin by Kylin.160 Later on, McNeely
Table 2. Examples of sulfated polysaccharides extracted and identified in
green algae
Alga Polysaccharide(s) References
Bryopsis plumosa Rhamnan sulfate 198
Chaetomorpha aerea Sulfated galactan 147
Codium dwarkense Sulfated arabinan
Sulfated arabinogalactan
113
Codium fragile Sulfated
arabinogalactans
Pyruvylated galactan
sulfate
104,107,108
Codium vermilara Sulfated mannan 112
Codium yezoense Pyruvylated galactan
sulfate
109,111,140
Monostroma latissimum Rhamnan sulfate 115-117
Monostroma nitidum Rhamnan sulfate 110,114
Ulva lactuca Sulfated rhaman 118,119
Ulva rigida Sulfated rhaman 123,124
Ulva rotundata Sulfated rhaman 120,121
Enteromorpha
compressa
Sulfated rhaman 122,125
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named it fucoidan following polysaccharide nomenclature,161,162
but according to a simple PubMedTM search, only around the
1970s this polymer was mentioned for the first time in the
medical literature.
The extraction of fucoidan from brown algae, as of other
sulfated polysaccharides from the respective macroalgae, is hot-
water based, with precipitation with salts or organic solvents.34
Nevertheless, the production of valuable polysaccharides follows a
more complex procedure, adding additional steps to render more
pure materials, dependent on their further use. In the case of
fucoidan, its extraction procedure has been methodically studied
to develop economically and industrially viable systems (Fig. 2).
The process can be divided in three steps: milling seaweeds,
extraction/purification (involves multiple, extended aqueous
Table 3. Biological effects associated with sulfated polysaccharides from green algae
Activity Alga References
Antioxidant Caulerpa cupressoides
C. prolifera
C. sertularioides
Chaetomorpha moniligera
Codium fragile
C. isthmocladum
Enteromorpha intestinalis
Ulva pertusa
U. lactuca
129-135
Antitumoral and antiproliferative activities Caulerpa cupressoides
C. prolifera
C. sertularioides
Codium isthmocladum
Enteromorpha intestinalis Ulva lactuca
129,131,136
Immunostimulating Codium tomentosum
C. fragile
Enteromorpha sp
Ulva rigida
137-141
Anticoagulant Bryopsis plumosa
Boodlea composite
Caulerpa cupressoides
C. prolifera
C. sertularioides
C. okamurai
C. brachypus
C. racemosa
C. taxifolia
C. scalpelliformis
C. veravalensis
C. peltata
Chaetomorpha media
C. torta
Cladophora fascicularis
Codium isthmocladum
C. divaricatum
C. adhaerence
C. latum
C. fragile
Enteromorpha clathrata
E. compressa
Monostroma latissimum
M. nitidum
Ulva lactuca
U. fasciata
U. reticulata
Valoniopsis pachynema
115-117,129,131,150-152
Antihyperlipidemic Ulva pertusa
U. lactuca
130,143-145
Antiviral Codium fragile
Gayralia oxysperma Monostroma nitidum
Ulva sp
U. lactuca
110,111,131,146-148
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extractions and acidic solutions and may include calcium to
promote the alginate precipitation and obtain fucoidan) and
drying/careful storage. This type of extraction can obtain yields of
fucoidan (%) ranging from 0.26% to 20% of algal biomass dry
weight.163 The physic-chemical characteristics of the extracted
fucoidan are dependent on the severity of the treatments in the
extraction such as temperature, reaction time, concentration of
the chemicals, as well as on inherent factors of algae, such as
species and size of algae, local climate and environmental
factors.164-166
Different chemical structures have been proposed for this
polysaccharide, since its discovery by Kylin. Fucoidan is a
heteropolysaccharide and its composition differs depending on the
sources and seasonality. The chemical composition of most
fucoidan is complex. Fucoidan structure can be divided into two
groups depending on their sources: one group includes Laminaria
species that have their central chains composed by (1A3)-linked
a-L-fucopyranose residues; a second group includes fucoidan
isolated from Ascophyllum and Fucus species that have their central
chains composed of repeating (1A3) and (1A4) linked a-L-
fucopyranose residues.158,167 Besides fucose and sulfate, the
presence of monosaccharide residues such as mannose, galactose,
glucose, xylose and uronic acids were also identified.165
Nevertheless, the chemical structure of fucoidan can be
schematically illustrated as showed in Figure 3.
The molecular weight of fucoidan varies from 13 kDa to 950
kDa164 and it depends also on many factors such as source, season
and extraction method from which they are obtained. In addition,
knowledge on the solubility and rheological properties of fucoidan
is important for different applications.168 In this perspective,
recent studies reported that rheological characteristics and
viscosity of fucoidan are different according to the algae species,
but independent of the molecular weight and proportion of
sulfates and uronic acids.169,170 One of those studies, developed by
Rioux and coworkers, report that fucoidan may not be capable to
form a gel, but a viscous solution.170
As for the previously reviewed sulfated polysaccharides, several
different bioactivities have been attributed to fucoidan and its
oligosaccharides. These bioactivities include anti-tumoral
effects,171 anti-coagulant,172-175 anti-viral176-179 and anti-inflama-
tory activities.171 These properties are related to molecular size,
type of sugar, sulfation degree and molecular geometry.
Based on the reported activities, fucoidan has been founding
application mainly in cosmetic industry (skin exfoliation, acne
treatment, hair hydration and tooth paste), food industry (dietetic
fibers, cholesterol reducer, functional fibers, sports beverage and
processed meat products) and biopharmaceutical industry
(immunologic, antiviral and anticoagulant).180-182 Moreover,
fucoidan is presently emerging as a popular potential and natural
ingredient to be used in cosmeceuticals industry. Some
epidemiological studies suggested that fucoidan has some skin
protecting, antioxidant and anti-aging activities.183
The interest in fucoidan has also been extended to biomedical-
related fields, such as drug delivery, nanomedicine and tissue
engineering applications. For instance, Sezer and coworkers
reported the development of a new microspheres delivery system
based on cross-linking of fucoidan with chitosan (Fucosphere),
Figure 2. Extraction of fucoidan from brown seaweeds.
Figure 3. Chemical structure of fucoidan (Adapted from ref180).
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with extent of drug release being dependent on the concentrations
of the polymers and protein.184 Alternatively, other authors
reported the development of chitosan/fucoidan pH-sensitive
nanoparticles for oral administration of drugs.185 The complexa-
tion of fucoidan with chitosan has been explored on the
development of nanoparticles with increased potential for the
delivery of anticoagulant agents taking advantage of its antith-
rombotic agents.185 In addition to delivery of bioactive agents, it
was also reported the ability of fucoidan to stimulate the
production of hepatocyte growth factor (HGF),186 thus reinfor-
cing the potential of this algae-derived biomaterial for health-
related applications.
Regarding tissue engineering, in particular considering cell
support systems (since drug delivery and growth factor regulatory
roles are also relevant), most of the studies investigate fucoidan in
combination with different polymers as e.g., chitosan,187
alginate188 or polycaprolactone (PCL),189,190 processed into
hydrogels, scaffolds, films and nanofibers. This may relate to
the great solubility of fucoidan in water and the difficulty in
forming gels. In this regard, the mixture with natural or synthetic
polymers, modified structure or chemical cross-linking is critical
for its further application. For instance, Sezer and coworkers
propose a fucoidan-chitosan hydrogel to be applied as burn
injuries healing accelerator on rabbits.191 The authors report the
use of chitosan due to its hydrogel forming properties and
advantageous use in applications as wound dressing material,
adding to the anti-coagulant activity of fucoidan, among other
properties. By their turn, Murakami and coworkers developed a
hydrogel sheet by blending alginate, chitosan and fucoidan,
aiming to stimulate rapid wound healing in rats.188 Besides
polysaccharides, fucoidan has been also blended with polyesters,
namely PCL, following a general melt-plotted process.189 This
rapid-prototyping methodology provided a system with an
appropriate pore structure for bone tissue regeneration, where
low molecular weight fucoidan was used to induce not only cell
proliferation but additionally influence on osteoconductive
properties including alkaline phosphatase activity, collagen Type
I expression and mineral deposition. Alternatively, micro/
nanofibrous scaffolds of PCL and fucoidan have been produced
by using an electrospinning process, aimed for application in bone
regenerative medicine.190
Final Remarks
Since ancient times, human efforts to treat and recover tissues
have been constinuously made.192 Among these, regenerative
medicine has brought new hopes for the treatment of inumerous
diseases and conditions. Although the tissue engineering and stem
cell industry is now close to breaking even,193 technological
challenges remain high.
Many tissue-engineered products (TEPs) under development
rely on the use of medical devices and/or materials to assure its
efficacy. So, the quest for new and improved materials remains a
pivotal pillar for the development and marketing authorization of
many products. Modulating and controlling cell response through
novel biomaterials chemistry and surface is an attractive approach
for development of new technology platforms that can, in
principle, sustain intellectual property development strategies. In
this regard, biomaterials that can bring exquisite properties and
improve biological performance of TEPs will continue to justify
research and investment.
Like never before, marine species constitute an inspirational
template for development of new biomedical technology. The
evolution of animal and vegetal species in marine ecossytems has
originated an extensive library of biomolecules with enormous
human application potential.
Marine polysaccharides remain an untapped reservoir for
development of novel biomaterials.
Sulfate groups can effectively modulate cell behavior in tissue
regeneration contexts, which may constitute an opportunity for
exploiting the clinical potential of marine origin sulfated
polysaccharides. These polymers do not have a true mammalian
analog and exhibit a high application potential across many
different regenerative medicine applications.
The realization of clinical potential of these polysaccharides will
be a long and challenging road, as the regulatory context of
medical devices and advanced therapy medicinal products, in
particular, are very demanding. The lack of industrial scale
extraction and purification of many of these molecules remains an
obstacle for their application development. In fact, a fundamental
requirement for any clinical application will be related with
development and validation of manufacturing methods. In some
cases, the extraction route may not be a possible manufacturing
strategy, as the scarcity of the raw materials, attainable purity
levels or final cost may be incompatible with industrialization.
Synthesis of surrogate or close analog molecules may be, in some
cases, the only cost effective approach.
In spite of the manufacturing strategy adopted, the natural
provenience and novelty of these materials imposes a strict control
of their purity, stability and safety, which imply extensive and,
above all, expensive studies. More than proving additional and or
incremental benefits in discrete application contexts, the challenge
ahead for any sulfated polysaccharide will be to gain its status as a
new biomaterial. For that, sulfated polysaccharides will have to
demonstrate outstanding application performance, scalable man-
ufacturing, remarkable cost-benefit potential, while addressing a
tangible market opportunity.
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